Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,095,333
-
Share change
-
-8,189,953
-
Total reported value
-
$801,000
-
Price per share
-
$0.20
-
Number of holders
-
20
-
Value change
-
-$6,520,127
-
Number of buys
-
6
-
Number of sells
-
13
Institutional Holders of AEVI GENOMIC MEDICINE INC - COM (GNMX) as of Q1 2019
As of 31 Mar 2019,
AEVI GENOMIC MEDICINE INC - COM (GNMX) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,095,333 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., VANGUARD GROUP INC, Virtu Financial LLC, ACADIAN ASSET MANAGEMENT LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, Birchview Capital, LP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and UBS Group AG.
This page lists
20
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.